Hi everyone, what an interesting thread. I haven't been able to read through the whole thing yet so I hope I'm not covering old ground but is this the general idea of what is going on.
LDN, baclofen and opioids help some people by way of raising endorphins which in turn reduce cytokines and brain inflammation?
If so has anyone been able to work out who they will likely have a positive effect on in regards to what started the illness to begin with or what is driving it? Eg. Does it tend to work better in those with known current infections etc.
Are there any Drs or researchers that have or are looking into this?
And the big question of course is what is causing these problems in the brain to begin with?
Ongoing infection or something like Dr Lloyds proposal that he just spoke on about people's genes/immune systems reacting to an event or infection that may have already past?
It's primarily that opioids clear the head and prevent PEM. LDN works as a step in this direction, at least for me. GHB does just as well as opioids if not better, as it also counters excitotoxicity by working on the GABA system. Baclofen can be a useful drug but it doesn't have the same effect as these.
I've at leasat a couple tick-borne infections, primarily borrelia and babesia. I understand there are those out there who'd question this, but I'll just say I'm absolutely convinced of this. Does this pertain to my response to endorphins? I don't know.
I suspect endorphins are neuroprotective. So whether one is suffering hits from infection, toxins, auto-immunity, etc the endorphins act to cool the inflammation.
I was just listening to the Jared Younger presentation at Stonford the other night, and he goes into the correlation between leptin and levels of fatigue, and explains how microglia become hyperexcitable. He suggests essentially all the above as possible hits. Interestingly he also mentions longterm opioid use as being able to prime microglia. I wonder if it's not the addiction to opioids and subsequent withdrawal that leads to primed microglia. This might suggest it can work the other way around and opioids can calm irascible microglia. At least that's my guess. That could explain what some of us are experiencing.
I also think his leptin correlation might suggest something like the CIRS Shoemaker talks about might be more common than we'd thought in our population. I know it certainly applies to me. I'm intrigued by Dr Younger's finding that if one pretreats with leptin the response to LPS on microglia is far greater. To me, again, this is hugely suggestive of CIRS and would correspond to my anecdotal observations.